14-day Premium Trial Subscription Sign Up For FreeGet Free

Big movements in Oncology Pharma Inc. stock price on Friday moving 10.96% between high and low

StockInvest.us, 3 months ago

StockInvest.us

The Oncology Pharma Inc. stock price gained 9.73% on the last trading day (Friday, 11th Jun 2021), rising from $28.99 to $31.81. , and has now gained 9 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the day the stock fluctuated 10.96% from a day low at $29.11 to a day high of $32.30. The price has risen in 8 of the last 10 days and is up by 32.54% over the past 2 weeks. Volume fell on the last day by -5 thousand shares and in total, 453 thousand shares were bought and sold for approximately $14.40 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.Given the current short-term trend, the stock is expected to fall -3.79% during the next 3 months and, with a 90% probability hold a price between $15.77 and $37.49 at the end of this 3-month period.

Oncology Pharma Inc.

Mostly positive signals in the chart today. The Oncology Pharma Inc. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $25.69 and $26.55. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, May 20, 2021, and so far it has risen 68.66%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Oncology Pharma Inc. finds support from accumulated volume at $30.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $3.19 between high and low, or 10.96%. For the last week, the stock has had a daily average volatility of 8.10%.

Since the Oncology Pharma Inc. has been rising for 9 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Check full Oncology Pharma Inc. forecast and analysis here.